Cell-cycle control protein expression Is disrupted in anogenital condylomata infected with low-risk human papillomavirus types

Journal of Lower Genital Tract Disease

Volumn 12, Issue 3, 2008, Pages 224-231

  Lyman, Rachel C ^a   Wilson, Mary L ^a   Herrington, C Simon ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Condyloma; Cyclin; P21; P53; Papillomavirus

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROTEIN P21; VIRUS DNA; CASPASE 3; CELL CYCLE PROTEIN; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ARTICLE; CELL CYCLE REGULATION; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA REPLICATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION RISK; KERATINOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; UPREGULATION; WART VIRUS; ADULT; GYNECOLOGIC DISEASE; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

ADULT; CASPASE 3; CELL CYCLE PROTEINS; CONDYLOMATA ACUMINATA; CYCLIN A; CYCLIN B; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 50549095051     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318166eff2     Document Type: Article

References (29)

1. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288: F55-78.
2. Chow LT, Broker TR. Small DNA Tumor Viruses. Philadelphia, PA: Lippincott-Raven Publishers; 1997.
3. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papilloma-virus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33: 901-5.
4. Jenson B, Lancaster WD. Association of human papillomavirus with benign, premalignant and malignant anogenital lesions. CRC Press; 1990.
5. Stoler MH, Broker TR. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 1986;17:1250-8.
6. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989;172:331-40.
7. Beyer-Finkler E, Stoler MH, Girardi F, Pfister H. Cell differentiation-related gene expression of human papilloma-virus 33. Med Microbiol Immunol (Berl) 1990;179:185-92.
8. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994;125:625-38.
9. Southern SA, Herrington CS. Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res 1998;58:2941-5.
10. Southern SA, McDicken IW, Herrington CS. Evidence for keratinocyte immortalization in high-grade squamous intraepithelial lesions of the cervix infected with high-risk human papillomaviruses. Lab Invest 2000;80:539-44.
11. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-105.
12. Talis AL, Huibregtse JM, Howley PM. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 1998;273:6439-45.
13. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
14. Giannoudis A, Herrington CS. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses. Cancer 2000;89:1300-7.
15. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 2000;74:6622-31.
16. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-44.
17. Jian Y, Schmidt-Grimminger DC, Chien WM, Wu X, Broker TR, Chow LT. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes. Oncogene 1998;17:2027-38.
18. Chien WM, Noya F, Benedict-Hamilton HM, Broker TR, Chow LT. Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation. J Virol 2002;76:2964-72.
19. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639-49.
20. Banerjee NS, Genovese NJ, Noya F, Chien WM, Broker TR, Chow LT. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol 2006; 80:6517-24.
21. Jian Y, Van Tine BA, Chien WM, Shaw GM, Broker TR, Chow LT. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis. Cell Growth Differ 1999;10:101-11.
22. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995;15: 2612-24.
23. Martin LG, Demers GW, Galloway DA. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol 1998;72:975-85.
24. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 1995;9:2335-49.
25. Zehbe I, Ratsch A, Alunni-Fabbroni M, Burzlaff A, Bakos E, Durst M, et al. Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions. Oncogene 1999;18:2201-11.
26. Heidebrecht HJ, Buck F, Haas K, Wacker HH, Parwaresch R. Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins. Cell Prolif 1996;29: 413-25.
27. Raj K, Berguerand S, Southern S, Doorbar J, Beard P. E1E4 protein of human papillomavirus type 16 associates with mitochondria. J Virol 2004;78:7199-207.
28. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11- associated recurrent respiratory papillomatosis is more aggressive than human papilloma-virus-6-associated disease. Pediatr Dev Pathol 2001;4: 68-72.
29. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004;114:1-23.